ArticleInternational journal of surgical oncology2011
Colorectal liver metastases.
Article in International journal of surgical oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Open versus laparoscopic liver resection of colorectal metastases: a meta-analysis of matched patient populations.Irish journal of medical science · 2022Pooled it
- The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.Clinical & experimental metastasis · 2013Pooled it
- Diagnostic performance of abbreviated non-contrast liver MRI for detecting synchronous colorectal liver metastases.PloS one · 2026Article
- Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolization.Frontiers in oncology · 2024Article
- HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target.Cell death discovery · 2023Article
- Article
- Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.European radiology · 2021Article
- Perioperative Outcomes Following Combined Versus Isolated Colorectal and Liver Resections:Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2021Article
- Article
- Quantitative Imaging Biomarkers forJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019Article
- Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases.BMC medical imaging · 2018Article
- The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases.European journal of clinical pharmacology · 2018Observational
- Oncogenic function of angiopoietin-2Oncology letters · 2017Article
- Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors.Radiation oncology journal · 2017Article
- Enhanced colorectal cancer metastases in the alcohol-injured liver.Clinical & experimental metastasis · 2017Article
- Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT.Cardiovascular and interventional radiology · 2016Article
- Liver Resection for Non-Colorectal Liver Metastases - Standards and Extended Indications.Viszeralmedizin · 2015Review
- Observational
- Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.European radiology · 2015Article
- Repeat hepatic resection in patients with colorectal liver metastases.World journal of gastroenterology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The diagnosis and management of CRLM is complex and requires a multidisciplinary team approach for optimal outcomes. Over the past several decades, the 5-year survival following resection of CRLM has increased and the criteria for resection have broadened substantially. Even patients with multiple, bilateral CRLM, previously thought unresectable, may now be candidates for resection. Two-stage hepatectomy, repeat curative-intent hepatectomy, and even selected resection of extrahepatic metastases have further increased the number of patients who may be treated with curative intent. Multiple liver-directed therapies exist to treat unresectable, incurable patients with adequate survival benefit and morbidity rates.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.